A Geomagnetic Storm is on the cards, which could potentially destroy electronics, cause power grid failures and more on Earth. An X2-class solar flare erupted on a freshly formed sunspot AR3229 just days ago on February 17. This flare was hurled out in the Earth’s direction by the Sun and has been travelling towards the planet. Experts now expect this solar flare to reach Earth today and it could spark a dangerous Geomagnetic storm.
According to a report by spaceweather.com, the X2-class solar flare, which was hurled towards Earth by Sunspot AR3229, could hit Earth as soon as today and spark a G1-class Geomagnetic storm, as per National Oceanic and Atmospheric Administration forecasters. The report stated, “NOAA forecasters say that minor G1-class geomagnetic storms are possible on Feb. 20th when a CME launched by Friday’s X2-class solar flare reaches Earth.” NASA and NOAA have conflicting reports on the matter. NOAA’s model predicts nothing more than a glancing blow when the solar flare hits Earth, while NASA’s model says it could cause a stronger G2 or G3-class Geomagnetic storm.
What can this solar activity do?
When solar particles hit Earth, the radio communications and the power grid is affected when it hits the planet’s magnetic field. It can cause power and radio blackouts for several hours or even days. However, electricity grid problems occur only if the solar flare is extremely large. Geomagnetic storms are also the reason behind stunning streaks of green light across the sky known as Northern Lights or Aurora Borealis.
Factors driving solar activity
The Sun entered solar cycle 25 in 2019 and it is expected that it will hit its peak in July 2025. And this is the main reason why the Sun has suddenly become so violent. The Earth is in for a rough ride. If the Earth is hit with a G5-class solar storm, it can not only damage satellites and disrupt wireless communications such as internet services, mobile network and GPS, it can also cause power grid failures and even disrupt electronics such as heatt pacemakers in patients.